Results
|
|
1381.
|
|
|
|
1382.
|
|
|
|
1383.
|
Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF. [electronic resource] by
- Fong, Lawrence
- Kwek, Serena S
- O'Brien, Shaun
- Kavanagh, Brian
- McNeel, Douglas G
- Weinberg, Vivian
- Lin, Amy M
- Rosenberg, Jonathan
- Ryan, Charles J
- Rini, Brian I
- Small, Eric J
Producer: 20090220
In:
Cancer research vol. 69
Availability: No items available.
|
|
|
1384.
|
|
|
|
1385.
|
|
|
|
1386.
|
|
|
|
1387.
|
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer. [electronic resource] by
- Rijavec, Erika
- Genova, Carlo
- Alama, Angela
- Barletta, Giulia
- Sini, Claudio
- Pronzato, Paolo
- Coco, Simona
- Dal Bello, Maria Giovanna
- Savarino, Graziana
- Truini, Anna
- Boccardo, Francesco
- Grossi, Francesco
Producer: 20140827
In:
Future oncology (London, England) vol. 10
Availability: No items available.
|
|
|
1388.
|
|
|
|
1389.
|
|
|
|
1390.
|
Health-related quality of life with adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): secondary outcomes of a multinational, randomised, double-blind, phase 3 trial. [electronic resource] by
- Coens, Corneel
- Suciu, Stefan
- Chiarion-Sileni, Vanna
- Grob, Jean-Jacques
- Dummer, Reinhard
- Wolchok, Jedd D
- Schmidt, Henrik
- Hamid, Omid
- Robert, Caroline
- Ascierto, Paolo A
- Richards, Jon M
- Lebbé, Celeste
- Ferraresi, Virginia
- Smylie, Michael
- Weber, Jeffrey S
- Maio, Michele
- Bottomley, Andrew
- Kotapati, Srividya
- de Pril, Veerle
- Testori, Alessandro
- Eggermont, Alexander M M
Producer: 20170608
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
|
1391.
|
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis. [electronic resource] by
- Wang, Yinghong
- Wiesnoski, Diana H
- Helmink, Beth A
- Gopalakrishnan, Vancheswaran
- Choi, Kati
- DuPont, Hebert L
- Jiang, Zhi-Dong
- Abu-Sbeih, Hamzah
- Sanchez, Christopher A
- Chang, Chia-Chi
- Parra, Edwin R
- Francisco-Cruz, Alejandro
- Raju, Gottumukkala S
- Stroehlein, John R
- Campbell, Matthew T
- Gao, Jianjun
- Subudhi, Sumit K
- Maru, Dipen M
- Blando, Jorge M
- Lazar, Alexander J
- Allison, James P
- Sharma, Padmanee
- Tetzlaff, Michael T
- Wargo, Jennifer A
- Jenq, Robert R
Producer: 20190508
In:
Nature medicine vol. 24
Availability: No items available.
|
|
|
1392.
|
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial. [electronic resource] by
- Hodi, Frank Stephen
- Chiarion-Sileni, Vanna
- Gonzalez, Rene
- Grob, Jean-Jacques
- Rutkowski, Piotr
- Cowey, Charles Lance
- Lao, Christopher D
- Schadendorf, Dirk
- Wagstaff, John
- Dummer, Reinhard
- Ferrucci, Pier Francesco
- Smylie, Michael
- Hill, Andrew
- Hogg, David
- Marquez-Rodas, Ivan
- Jiang, Joel
- Rizzo, Jasmine
- Larkin, James
- Wolchok, Jedd D
Producer: 20190610
In:
The Lancet. Oncology vol. 19
Availability: No items available.
|
|
|
1393.
|
|
|
|
1394.
|
|
|
|
1395.
|
|
|
|
1396.
|
|
|
|
1397.
|
|
|
|
1398.
|
|
|
|
1399.
|
|
|
|
1400.
|
Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial. [electronic resource] by
- Ascierto, Paolo A
- Del Vecchio, Michele
- Robert, Caroline
- Mackiewicz, Andrzej
- Chiarion-Sileni, Vanna
- Arance, Ana
- Lebbé, Céleste
- Bastholt, Lars
- Hamid, Omid
- Rutkowski, Piotr
- McNeil, Catriona
- Garbe, Claus
- Loquai, Carmen
- Dreno, Brigitte
- Thomas, Luc
- Grob, Jean-Jacques
- Liszkay, Gabriella
- Nyakas, Marta
- Gutzmer, Ralf
- Pikiel, Joanna
- Grange, Florent
- Hoeller, Christoph
- Ferraresi, Virginia
- Smylie, Michael
- Schadendorf, Dirk
- Mortier, Laurent
- Svane, Inge Marie
- Hennicken, Delphine
- Qureshi, Anila
- Maio, Michele
Producer: 20170810
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|